CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
41.80
+0.13 (0.31%)
Feb 13, 2026, 4:00 PM EST - Market closed
CONMED Revenue
In the year 2025, CONMED had annual revenue of $1.37B with 5.18% growth. CONMED had revenue of $373.20M in the quarter ending December 31, 2025, with 7.88% growth.
Revenue (ttm)
$1.37B
Revenue Growth
+5.18%
P/S Ratio
0.94
Revenue / Employee
$352,493
Employees
3,900
Market Cap
1.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 67.71M | 5.18% |
| Dec 31, 2024 | 1.31B | 62.27M | 5.00% |
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% |
| Dec 31, 2019 | 955.10M | 95.46M | 11.11% |
| Dec 31, 2018 | 859.63M | 63.24M | 7.94% |
| Dec 31, 2017 | 796.39M | 32.87M | 4.31% |
| Dec 31, 2016 | 763.52M | 44.35M | 6.17% |
| Dec 31, 2015 | 719.17M | -20.89M | -2.82% |
| Dec 31, 2014 | 740.06M | -22.65M | -2.97% |
| Dec 31, 2013 | 762.70M | -4.44M | -0.58% |
| Dec 31, 2012 | 767.14M | 42.06M | 5.80% |
| Dec 31, 2011 | 725.08M | 11.35M | 1.59% |
| Dec 31, 2010 | 713.72M | 18.98M | 2.73% |
| Dec 31, 2009 | 694.74M | -47.44M | -6.39% |
| Dec 31, 2008 | 742.18M | 47.90M | 6.90% |
| Dec 31, 2007 | 694.29M | 47.48M | 7.34% |
| Dec 31, 2006 | 646.81M | 29.51M | 4.78% |
| Dec 31, 2005 | 617.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.26B |
| QuidelOrtho | 2.73B |
| Enovis | 2.23B |
| Tandem Diabetes Care | 1.01B |
| Inspire Medical Systems | 911.98M |
| NovoCure | 642.27M |
| UFP Technologies | 597.95M |
| InMode | 370.50M |
CNMD News
- 16 days ago - CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results - Business Wire
- 4 weeks ago - CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - CONMED Corporation Announces Chief Financial Officer Transition - Business Wire
- 5 weeks ago - CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 5 weeks ago - CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026 - Business Wire
- 2 months ago - CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines - Business Wire
- 3 months ago - CONMED Corporation (CNMD) Q3 2025 Earnings Call Transcript - Seeking Alpha